Effects of butyric acid, a bacterial metabolite, on the migration of ameloblastoma mediated by laminin 332.


Journal

Journal of oral science
ISSN: 1880-4926
Titre abrégé: J Oral Sci
Pays: Japan
ID NLM: 9808942

Informations de publication

Date de publication:
26 Sep 2020
Historique:
pubmed: 4 9 2020
medline: 30 9 2020
entrez: 4 9 2020
Statut: ppublish

Résumé

Ameloblastoma is a benign tumor that develops in the jawbone. Occasionally, however, it may become malignant and metastasize to other tissues. Although it has been suggested that various cytokines and several adhesion factors may play a role in its malignant transformation, the details have not been elucidated. In this context, it has been reported that butyric acid produced by periodontopathic bacteria causes progression of malignant tumors occurring in the mouth via podoplanin. However, the influence of butyric acid on ameloblastoma has not been clarified. In the present study, therefore, the expression of various cytokines and adhesion factors in ameloblastoma upon stimulation with butyric acid or cytokines was investigated using real-time reverse-transcription polymerase chain reaction. Three cell lines (HAM1, HAM2 and HAM3) established from the same ameloblastoma were used in the experiments. It was found that the expression of mRNAs for epidermal growth factor (EGF) and transforming growth factor beta 1 (TGFβ1) was increased in HAM2 and HAM3, respectively, upon stimulation with butyric acid. In addition, stimulation with EGF and TGFβ1 led to an increase in the expression of laminin β-3 mRNA in the respective cell lines. These results suggest that butyric acid may be involved in ameloblastoma exacerbation through the expression of laminin 332 (LM332) via EGF and TGFβ1 produced by ameloblastoma itself.

Identifiants

pubmed: 32879156
doi: 10.2334/josnusd.19-0380
doi:

Substances chimiques

Cell Adhesion Molecules 0
Butyric Acid 107-92-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-438

Auteurs

Taichi Ishikawa (T)

Division of Molecular Microbiology, Department of Microbiology, Iwate Medical University.

Jun Terashima (J)

Division of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University.

Yu Shimoyama (Y)

Division of Molecular Microbiology, Department of Microbiology, Iwate Medical University.

Yu Ohashi (Y)

Division of Oral and Maxillofacial Surgery, Department of Reconstructive Oral and Maxillofacial Surgery, School of Dentistry, Iwate Medical University.

Toshinari Mikami (T)

Pax Creation Medical Lab.

Yasunori Takeda (Y)

Division of Clinical Pathology, Department of Oral and Maxillofacial Reconstructive Surgery, School of Dentistry, Iwate Medical University.

Minoru Sasaki (M)

Division of Molecular Microbiology, Department of Microbiology, Iwate Medical University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH